BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36093169)

  • 1. Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension.
    Prisco SZ; Hartweck L; Keen JL; Vogel N; Kazmirczak F; Eklund M; Hemnes AR; Brittain EL; Prins KW
    Front Cardiovasc Med; 2022; 9():940932. PubMed ID: 36093169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Eklund M; Raveendran R; Thenappan T; Prins KW
    JACC Basic Transl Sci; 2021 Nov; 6(11):834-850. PubMed ID: 34869947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
    Prisco SZ; Hartweck LM; Rose L; Lima PDA; Thenappan T; Archer SL; Prins KW
    Circ Heart Fail; 2022 Jan; 15(1):e008574. PubMed ID: 34923829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
    Prisco SZ; Eklund M; Moutsoglou DM; Prisco AR; Khoruts A; Weir EK; Thenappan T; Prins KW
    J Am Heart Assoc; 2021 Nov; 10(22):e022722. PubMed ID: 34747187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.
    Spyropoulos F; Michael Z; Finander B; Vitali S; Kosmas K; Zymaris P; Kalish BT; Kourembanas S; Christou H
    Front Cardiovasc Med; 2021; 8():662870. PubMed ID: 34222363
    [No Abstract]   [Full Text] [Related]  

  • 6. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
    Legchenko E; Chouvarine P; Borchert P; Fernandez-Gonzalez A; Snay E; Meier M; Maegel L; Mitsialis SA; Rog-Zielinska EA; Kourembanas S; Jonigk D; Hansmann G
    Sci Transl Med; 2018 Apr; 10(438):. PubMed ID: 29695452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.
    Tian L; Neuber-Hess M; Mewburn J; Dasgupta A; Dunham-Snary K; Wu D; Chen KH; Hong Z; Sharp WW; Kutty S; Archer SL
    J Mol Med (Berl); 2017 Apr; 95(4):381-393. PubMed ID: 28265681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and Treatment of Endoplasmic Reticulum (ER) Stress in Right Ventricular Dysfunction during Monocrotaline-Induced Rat Pulmonary Arterial Hypertension.
    Wang JJ; Zuo XR; Xu J; Zhou JY; Kong H; Zeng XN; Xie WP; Cao Q
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):587-598. PubMed ID: 27844183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
    Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
    J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific.
    Talati M; Brittain E; Agrawal V; Fortune N; Simon K; Shay S; Zeng X; Freeman ML; West J; Hemnes A
    Front Med (Lausanne); 2023; 10():1276422. PubMed ID: 37869164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
    Rabbani N; Thornalley PJ
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.
    Xue M; Rabbani N; Momiji H; Imbasi P; Anwar MM; Kitteringham N; Park BK; Souma T; Moriguchi T; Yamamoto M; Thornalley PJ
    Biochem J; 2012 Apr; 443(1):213-22. PubMed ID: 22188542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
    Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.
    Gomez-Arroyo J; Mizuno S; Szczepanek K; Van Tassell B; Natarajan R; dos Remedios CG; Drake JI; Farkas L; Kraskauskas D; Wijesinghe DS; Chalfant CE; Bigbee J; Abbate A; Lesnefsky EJ; Bogaard HJ; Voelkel NF
    Circ Heart Fail; 2013 Jan; 6(1):136-44. PubMed ID: 23152488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
    Archer SL; Fang YH; Ryan JJ; Piao L
    Pulm Circ; 2013 Jan; 3(1):144-52. PubMed ID: 23662191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.